Françoise Accard

635 citations
11 papers · 495 indexed · h-index 7
Topics
Multiple Myeloma Research and Treatments (4 papers)Glycosylation and Glycoproteins Research (3 papers)Acute Myeloid Leukemia Research (3 papers)
Partner nations
France

In The Last Decade

Françoise Accard

11 papers receiving 484 citations

Peers

Françoise Accard
Comparison fields: 5 of 49
  • Hematology 279
  • Immunology 167
  • Molecular Biology 160
  • Oncology 124
  • Genetics 108
Replace JE Curtis with:
JE Curtis Canada
P Buchinger Austria
HJ Weinstein United States
Katie Seo United States
A Cantù-Rajnoldi Italy
RD Brunning United States
Jenny I. O. Craig United Kingdom
H. J. Adriaansen Netherlands
M C López-Berges Spain
JJ van Dongen Netherlands
Françoise Accard relative to JE Curtis Canada JE Curtis's profile →
Citations per field
00.5×12×
JE Curtis · 1×
Citations per year

Countries citing papers authored by Françoise Accard

Since Specialization
Citations

This map shows the geographic impact of Françoise Accard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Accard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Accard more than expected).

Fields of papers citing papers by Françoise Accard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Accard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Accard. The network helps show where Françoise Accard may publish in the future.

Co-authorship network of co-authors of Françoise Accard

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Accard. A scholar is included among the top collaborators of Françoise Accard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Accard. Françoise Accard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 69
2 2
3 13
4 54
5 115
6 134
7 3
8
In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients.
1
9 3
10 31
11 70

About Françoise Accard

Françoise Accard is a scholar working on Hematology, Genetics and Immunology, having authored 11 papers that have together received 495 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (279 citations), Genetics (108 citations) and Immunology (167 citations). Françoise Accard has collaborated with scholars based in France. Frequent co-authors include Régis Bataille, Jean‐Luc Harousseau, Richard Garand, Nelly Robillard, Gaëtan Jégo, Martine Amiot, Catherine Pellat‐Deceunynck, Denis Puthier, Danielle Pineau and Philippe Moreau. Their work appears in journals such as Blood, Leukemia and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026